Does anyone routinely use cytoplasmic CD3 or cytoplasmic CD22 for acute
leukemias? If so, what has been your experience? Are these markers
helpful? We are considering adding these to our panel.
Tim Singleton, MD
singleto@umich.edu
![]() |
![]() |
![]() |
![]() |
![]() |
CD-ROM Vol 3 was produced by Monica M. Shively and other staff at the
Purdue University Cytometry Laboratories and distributed free of charge
as an educational service to the cytometry community.
If you have any comments please direct them to
Dr. J. Paul Robinson, Professor & Director,
PUCL, Purdue University, West Lafayette, IN 47907.
Phone: (765)-494-0757;
FAX(765) 494-0517;
Web